Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
246
mi
from 43215
Altoona, PA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
246
mi
from 43215
Altoona, PA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
406
mi
from 43215
Norristown, PA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
406
mi
from 43215
Norristown, PA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
388
mi
from 43215
Red Lion, PA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
388
mi
from 43215
Red Lion, PA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
619
mi
from 43215
Providence, RI
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
619
mi
from 43215
Providence, RI
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
365
mi
from 43215
Clemson, SC
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
365
mi
from 43215
Clemson, SC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
426
mi
from 43215
Columbia, SC
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
426
mi
from 43215
Columbia, SC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
310
mi
from 43215
Hickory, SC
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
310
mi
from 43215
Hickory, SC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
363
mi
from 43215
Simpsonville, SC
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
363
mi
from 43215
Simpsonville, SC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
239
mi
from 43215
Bristol, TN
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
239
mi
from 43215
Bristol, TN
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1069
mi
from 43215
Austin, TX
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
991
mi
from 43215
Houston, TX
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
341
mi
from 43215
Richmond, VA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
2001
mi
from 43215
Everett, WA
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
2001
mi
from 43215
Everett, WA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  8/1/2016
5386
mi
from 43215
Buenos Aires,
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both.
Randomized, Active Controlled, Open Label Study to Compare Taspoglutide vs Exenatide as add-on Treatment to Metformin and/or Thiazolidinediones in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 8/1/2016
5386
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1965
mi
from 43215
Buena Park, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1965
mi
from 43215
Buena Park, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1943
mi
from 43215
Chino, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1943
mi
from 43215
Chino, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1935
mi
from 43215
Rancho Cucamonga, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1935
mi
from 43215
Rancho Cucamonga, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
2028
mi
from 43215
Roseville, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1960
mi
from 43215
Santa Ana, CA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
726
mi
from 43215
Chiefland, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
726
mi
from 43215
Chiefland, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
995
mi
from 43215
Coral Gables, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
995
mi
from 43215
Coral Gables, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
749
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
693
mi
from 43215
Panama City, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
693
mi
from 43215
Panama City, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
897
mi
from 43215
Port Charlotte, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
897
mi
from 43215
Port Charlotte, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
839
mi
from 43215
St Petersburg, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
839
mi
from 43215
St Petersburg, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
791
mi
from 43215
Winter Park, FL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
791
mi
from 43215
Winter Park, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
529
mi
from 43215
Columbus, GA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
529
mi
from 43215
Columbus, GA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
441
mi
from 43215
Conyers, GA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
441
mi
from 43215
Conyers, GA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
416
mi
from 43215
Roswell, GA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
416
mi
from 43215
Roswell, GA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
353
mi
from 43215
Springfield, IL
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
353
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
280
mi
from 43215
Evansville, IN
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
280
mi
from 43215
Evansville, IN
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
302
mi
from 43215
Madisonville, KY
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
302
mi
from 43215
Madisonville, KY
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
797
mi
from 43215
Metairie, LA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
797
mi
from 43215
Metairie, LA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
619
mi
from 43215
Ayer, MA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
619
mi
from 43215
Ayer, MA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
634
mi
from 43215
Waltham, MA
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
634
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
172
mi
from 43215
Ferndale, MI
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
172
mi
from 43215
Ferndale, MI
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
740
mi
from 43215
Biloxi, MS
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
740
mi
from 43215
Biloxi, MS
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
660
mi
from 43215
Jackson, MS
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
660
mi
from 43215
Jackson, MS
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
509
mi
from 43215
Olive Branch, MS
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
509
mi
from 43215
Olive Branch, MS
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
807
mi
from 43215
Grand Island, NE
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
807
mi
from 43215
Grand Island, NE
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
428
mi
from 43215
Berlin, NJ
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
471
mi
from 43215
Brick, NJ
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
471
mi
from 43215
Brick, NJ
Click here to add this to my saved trials
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
467
mi
from 43215
Toms River, NJ
A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes
A Multicenter, Randomized, Double Blind (Double Dummy), Active Controlled Study to Compare the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Pioglitazone in Type 2 Diabetes Patients Inadequately Controlled on Therapy With Sulfonylurea or Metformin Plus Sulfonylurea
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
467
mi
from 43215
Toms River, NJ
Click here to add this to my saved trials